Paul V

MD | Chief Medical Officer at ImmuneCyte, Inc.

No bio yet


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ImmuneCyte, Inc.

ImmuneCyte  is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells with chimeric antigen receptors, for the treatment of cancer, vascular, orthopaedic, and age-related illnesses. They have developed technological cell-based genetreatments on this platform to treat severe cases of b-thalassemia, a fatal blood genetic condition.


Employees

51-200

Links